Instil Bio Inc.
TIL | NASDAQ
$6.57
-$0.23 (-3.38%)
Nov 2, 2026, 2:24 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 138K |
Cost of Revenue | 534K | n/a | n/a | 5.99M | n/a | n/a |
Gross Profit | -534K | n/a | n/a | -5.99M | n/a | 138K |
Operating Income | -52.91M | -73.54M | -159.17M | -206.17M | -155.56M | -33.64M |
Interest Income | 3.86M | 6.99M | 8.87M | 3.66M | 80K | 70K |
Pretax Income | -71.37M | -74.14M | -156.09M | -225.25M | -156.76M | -37.59M |
Net Income | -71.37M | -74.14M | -156.09M | -223.18M | -156.79M | -37.74M |
Selling & General & Admin | 27.22M | 44.21M | 47.55M | 62.24M | 51.31M | 14.38M |
Research & Development | 10M | 11.84M | 39.6M | 141.06M | 107.25M | 19.4M |
Other Expenses | 15.15M | 17.49M | 72.01M | -3.11M | -3M | n/a |
Operating Expenses | 52.37M | 73.54M | 159.17M | 200.18M | 155.56M | 33.78M |
Interest Expense | 5.83M | 8.99M | 5.21M | 1.88M | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 3M | n/a |
Cost & Expenses | 52.91M | 73.54M | 159.17M | 206.17M | 155.56M | 33.78M |
Income Tax Expense | n/a | n/a | n/a | -2.07M | 39K | 151K |
Shares Outstanding (Basic) | 6.67M | 6.51M | 6.5M | 6.48M | 5.3M | 6.41M |
Shares Outstanding (Diluted) | 6.67M | 6.51M | 6.5M | 6.48M | 5.3M | 6.41M |
EPS (Basic) | -10.70 | -11.39 | -24 | -34.46 | -29.60 | -5.89 |
EPS (Diluted) | -10.70 | -11.39 | -24 | -34.46 | -29.60 | -5.89 |
EBITDA | -65.01M | -62.53M | -147.12M | -217.38M | -152.51M | -33.39M |
EBIT | -65.54M | -66.14M | -151.87M | -223.37M | -155.27M | -33.64M |
Depreciation & Amortization | 534K | 3.61M | 4.76M | 5.99M | 2.75M | 256K |
Add to Watchlist
Select watchlists to add or remove TIL